Competing risks analysis of cause‐specific mortality in patients with oral squamous cell carcinoma

Background Survival studies on head and neck cancers are frequently reported with inadequate account for competing causes of death. Realistic descriptions and predictions of postdiagnosis mortality should be based on proper competing risks methodology. Methods Prognosis of patients with oral squamou...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Head & neck 2017-01, Vol.39 (1), p.56-62
Hauptverfasser: Läärä, Esa, Korpi, Jarkko T., Pitkänen, Hanna, Alho, Olli‐Pekka, Kantola, Saara
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 62
container_issue 1
container_start_page 56
container_title Head & neck
container_volume 39
creator Läärä, Esa
Korpi, Jarkko T.
Pitkänen, Hanna
Alho, Olli‐Pekka
Kantola, Saara
description Background Survival studies on head and neck cancers are frequently reported with inadequate account for competing causes of death. Realistic descriptions and predictions of postdiagnosis mortality should be based on proper competing risks methodology. Methods Prognosis of patients with oral squamous cell carcinoma (OSCC) in terms of mortality from OSCC and from other causes, respectively, was analyzed according to recent methodological recommendations using cumulative incidence functions and models for cause‐specific hazards and subdistribution hazards in 306 patients treated in a tertiary care center in Northern Finland. Results More coherent and informative descriptions and predictions of mortality by cause were obtained with state‐of‐the‐art statistical methods for competing risks than using the prevalent but questionable practice to graph “disease‐specific survival.” Conclusion From the patients' perspective, proper competing risks analysis offers more relevant prognostic scenarios than naïve analyses of “disease‐specific survival”; therefore, it should be used in prognostic studies of head and neck cancers. © 2016 Wiley Periodicals, Head Neck 39: 56–62, 2017
doi_str_mv 10.1002/hed.24536
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1859471171</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1826721927</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4216-a29f776a5b5782beb622518015644c898dab127a83edc9fbaa8fb70bb9129a823</originalsourceid><addsrcrecordid>eNqN0ctKxDAUBuAgiveFLyABN7qok1uTdinjFQQ3ui4nmVSjbVOTFpmdj-Az-iRmnHEjCK4Swpc_h_wIHVBySglhkyc7O2Ui53INbVNSqoxwodYXe8EzTpTYQjsxPhNCuBRsE20xJbiSUm2j2dS3vR1c94iDiy8RQwfNPLqIfY0NjNF-vn_E3hpXO4NbHwZo3DDHrsM9DM52Q8RvbnjCPkCD4-sIrR8jNrZp0vVgXOdb2EMbNTTR7q_WXfRweXE_vc5u765upme3mRGMygxYWSslIde5Kpi2WjKW04LQXAphirKYgaZMQcHtzJS1BihqrYjWJWUlFIzvouNlbh_862jjULUuLkaBzqapKlrkpVCUKvoPyqRitGQq0aNf9NmPIX3TQon0Nmc0T-pkqUzwMQZbV31wLYR5RUm1aKlKLVXfLSV7uEocdZtOf-RPLQlMluDNNXb-d1J1fXG-jPwCTu6cYA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1849123215</pqid></control><display><type>article</type><title>Competing risks analysis of cause‐specific mortality in patients with oral squamous cell carcinoma</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Läärä, Esa ; Korpi, Jarkko T. ; Pitkänen, Hanna ; Alho, Olli‐Pekka ; Kantola, Saara</creator><creatorcontrib>Läärä, Esa ; Korpi, Jarkko T. ; Pitkänen, Hanna ; Alho, Olli‐Pekka ; Kantola, Saara</creatorcontrib><description>Background Survival studies on head and neck cancers are frequently reported with inadequate account for competing causes of death. Realistic descriptions and predictions of postdiagnosis mortality should be based on proper competing risks methodology. Methods Prognosis of patients with oral squamous cell carcinoma (OSCC) in terms of mortality from OSCC and from other causes, respectively, was analyzed according to recent methodological recommendations using cumulative incidence functions and models for cause‐specific hazards and subdistribution hazards in 306 patients treated in a tertiary care center in Northern Finland. Results More coherent and informative descriptions and predictions of mortality by cause were obtained with state‐of‐the‐art statistical methods for competing risks than using the prevalent but questionable practice to graph “disease‐specific survival.” Conclusion From the patients' perspective, proper competing risks analysis offers more relevant prognostic scenarios than naïve analyses of “disease‐specific survival”; therefore, it should be used in prognostic studies of head and neck cancers. © 2016 Wiley Periodicals, Head Neck 39: 56–62, 2017</description><identifier>ISSN: 1043-3074</identifier><identifier>EISSN: 1097-0347</identifier><identifier>DOI: 10.1002/hed.24536</identifier><identifier>PMID: 27437667</identifier><identifier>CODEN: HEANEE</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>Adolescent ; Adult ; Aged ; Aged, 80 and over ; Carcinoma, Squamous Cell - diagnosis ; Carcinoma, Squamous Cell - mortality ; Carcinoma, Squamous Cell - therapy ; cause‐specific mortality ; competing risks ; cumulative incidence ; Female ; Finland ; Humans ; Male ; Middle Aged ; Mouth Neoplasms - diagnosis ; Mouth Neoplasms - mortality ; Mouth Neoplasms - therapy ; Prognosis ; Retrospective Studies ; Risk Assessment ; survival ; Survival Analysis ; Survival Rate ; Young Adult</subject><ispartof>Head &amp; neck, 2017-01, Vol.39 (1), p.56-62</ispartof><rights>2016 Wiley Periodicals, Inc.</rights><rights>2017 Wiley Periodicals, Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4216-a29f776a5b5782beb622518015644c898dab127a83edc9fbaa8fb70bb9129a823</citedby><cites>FETCH-LOGICAL-c4216-a29f776a5b5782beb622518015644c898dab127a83edc9fbaa8fb70bb9129a823</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fhed.24536$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fhed.24536$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27437667$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Läärä, Esa</creatorcontrib><creatorcontrib>Korpi, Jarkko T.</creatorcontrib><creatorcontrib>Pitkänen, Hanna</creatorcontrib><creatorcontrib>Alho, Olli‐Pekka</creatorcontrib><creatorcontrib>Kantola, Saara</creatorcontrib><title>Competing risks analysis of cause‐specific mortality in patients with oral squamous cell carcinoma</title><title>Head &amp; neck</title><addtitle>Head Neck</addtitle><description>Background Survival studies on head and neck cancers are frequently reported with inadequate account for competing causes of death. Realistic descriptions and predictions of postdiagnosis mortality should be based on proper competing risks methodology. Methods Prognosis of patients with oral squamous cell carcinoma (OSCC) in terms of mortality from OSCC and from other causes, respectively, was analyzed according to recent methodological recommendations using cumulative incidence functions and models for cause‐specific hazards and subdistribution hazards in 306 patients treated in a tertiary care center in Northern Finland. Results More coherent and informative descriptions and predictions of mortality by cause were obtained with state‐of‐the‐art statistical methods for competing risks than using the prevalent but questionable practice to graph “disease‐specific survival.” Conclusion From the patients' perspective, proper competing risks analysis offers more relevant prognostic scenarios than naïve analyses of “disease‐specific survival”; therefore, it should be used in prognostic studies of head and neck cancers. © 2016 Wiley Periodicals, Head Neck 39: 56–62, 2017</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Carcinoma, Squamous Cell - diagnosis</subject><subject>Carcinoma, Squamous Cell - mortality</subject><subject>Carcinoma, Squamous Cell - therapy</subject><subject>cause‐specific mortality</subject><subject>competing risks</subject><subject>cumulative incidence</subject><subject>Female</subject><subject>Finland</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Mouth Neoplasms - diagnosis</subject><subject>Mouth Neoplasms - mortality</subject><subject>Mouth Neoplasms - therapy</subject><subject>Prognosis</subject><subject>Retrospective Studies</subject><subject>Risk Assessment</subject><subject>survival</subject><subject>Survival Analysis</subject><subject>Survival Rate</subject><subject>Young Adult</subject><issn>1043-3074</issn><issn>1097-0347</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqN0ctKxDAUBuAgiveFLyABN7qok1uTdinjFQQ3ui4nmVSjbVOTFpmdj-Az-iRmnHEjCK4Swpc_h_wIHVBySglhkyc7O2Ui53INbVNSqoxwodYXe8EzTpTYQjsxPhNCuBRsE20xJbiSUm2j2dS3vR1c94iDiy8RQwfNPLqIfY0NjNF-vn_E3hpXO4NbHwZo3DDHrsM9DM52Q8RvbnjCPkCD4-sIrR8jNrZp0vVgXOdb2EMbNTTR7q_WXfRweXE_vc5u765upme3mRGMygxYWSslIde5Kpi2WjKW04LQXAphirKYgaZMQcHtzJS1BihqrYjWJWUlFIzvouNlbh_862jjULUuLkaBzqapKlrkpVCUKvoPyqRitGQq0aNf9NmPIX3TQon0Nmc0T-pkqUzwMQZbV31wLYR5RUm1aKlKLVXfLSV7uEocdZtOf-RPLQlMluDNNXb-d1J1fXG-jPwCTu6cYA</recordid><startdate>201701</startdate><enddate>201701</enddate><creator>Läärä, Esa</creator><creator>Korpi, Jarkko T.</creator><creator>Pitkänen, Hanna</creator><creator>Alho, Olli‐Pekka</creator><creator>Kantola, Saara</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7TK</scope><scope>K9.</scope><scope>7X8</scope></search><sort><creationdate>201701</creationdate><title>Competing risks analysis of cause‐specific mortality in patients with oral squamous cell carcinoma</title><author>Läärä, Esa ; Korpi, Jarkko T. ; Pitkänen, Hanna ; Alho, Olli‐Pekka ; Kantola, Saara</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4216-a29f776a5b5782beb622518015644c898dab127a83edc9fbaa8fb70bb9129a823</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Carcinoma, Squamous Cell - diagnosis</topic><topic>Carcinoma, Squamous Cell - mortality</topic><topic>Carcinoma, Squamous Cell - therapy</topic><topic>cause‐specific mortality</topic><topic>competing risks</topic><topic>cumulative incidence</topic><topic>Female</topic><topic>Finland</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Mouth Neoplasms - diagnosis</topic><topic>Mouth Neoplasms - mortality</topic><topic>Mouth Neoplasms - therapy</topic><topic>Prognosis</topic><topic>Retrospective Studies</topic><topic>Risk Assessment</topic><topic>survival</topic><topic>Survival Analysis</topic><topic>Survival Rate</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Läärä, Esa</creatorcontrib><creatorcontrib>Korpi, Jarkko T.</creatorcontrib><creatorcontrib>Pitkänen, Hanna</creatorcontrib><creatorcontrib>Alho, Olli‐Pekka</creatorcontrib><creatorcontrib>Kantola, Saara</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Head &amp; neck</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Läärä, Esa</au><au>Korpi, Jarkko T.</au><au>Pitkänen, Hanna</au><au>Alho, Olli‐Pekka</au><au>Kantola, Saara</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Competing risks analysis of cause‐specific mortality in patients with oral squamous cell carcinoma</atitle><jtitle>Head &amp; neck</jtitle><addtitle>Head Neck</addtitle><date>2017-01</date><risdate>2017</risdate><volume>39</volume><issue>1</issue><spage>56</spage><epage>62</epage><pages>56-62</pages><issn>1043-3074</issn><eissn>1097-0347</eissn><coden>HEANEE</coden><abstract>Background Survival studies on head and neck cancers are frequently reported with inadequate account for competing causes of death. Realistic descriptions and predictions of postdiagnosis mortality should be based on proper competing risks methodology. Methods Prognosis of patients with oral squamous cell carcinoma (OSCC) in terms of mortality from OSCC and from other causes, respectively, was analyzed according to recent methodological recommendations using cumulative incidence functions and models for cause‐specific hazards and subdistribution hazards in 306 patients treated in a tertiary care center in Northern Finland. Results More coherent and informative descriptions and predictions of mortality by cause were obtained with state‐of‐the‐art statistical methods for competing risks than using the prevalent but questionable practice to graph “disease‐specific survival.” Conclusion From the patients' perspective, proper competing risks analysis offers more relevant prognostic scenarios than naïve analyses of “disease‐specific survival”; therefore, it should be used in prognostic studies of head and neck cancers. © 2016 Wiley Periodicals, Head Neck 39: 56–62, 2017</abstract><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>27437667</pmid><doi>10.1002/hed.24536</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1043-3074
ispartof Head & neck, 2017-01, Vol.39 (1), p.56-62
issn 1043-3074
1097-0347
language eng
recordid cdi_proquest_miscellaneous_1859471171
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Adolescent
Adult
Aged
Aged, 80 and over
Carcinoma, Squamous Cell - diagnosis
Carcinoma, Squamous Cell - mortality
Carcinoma, Squamous Cell - therapy
cause‐specific mortality
competing risks
cumulative incidence
Female
Finland
Humans
Male
Middle Aged
Mouth Neoplasms - diagnosis
Mouth Neoplasms - mortality
Mouth Neoplasms - therapy
Prognosis
Retrospective Studies
Risk Assessment
survival
Survival Analysis
Survival Rate
Young Adult
title Competing risks analysis of cause‐specific mortality in patients with oral squamous cell carcinoma
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T22%3A48%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Competing%20risks%20analysis%20of%20cause%E2%80%90specific%20mortality%20in%20patients%20with%20oral%20squamous%20cell%20carcinoma&rft.jtitle=Head%20&%20neck&rft.au=L%C3%A4%C3%A4r%C3%A4,%20Esa&rft.date=2017-01&rft.volume=39&rft.issue=1&rft.spage=56&rft.epage=62&rft.pages=56-62&rft.issn=1043-3074&rft.eissn=1097-0347&rft.coden=HEANEE&rft_id=info:doi/10.1002/hed.24536&rft_dat=%3Cproquest_cross%3E1826721927%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1849123215&rft_id=info:pmid/27437667&rfr_iscdi=true